Skip to main content
. 2022 Feb 15;10:384–392. doi: 10.1016/j.xjon.2022.02.001

Figure 2.

Figure 2

The overall survival for patients by treatment sequence alone was 31.7% at 5 years for surgery followed by chemotherapy with or without radiation (S + CR) and 11.5% at 4 years for surgery alone. Lines were truncated when the number of patients at risk fell fewer than 10 for the cohort. Shading above and below the lines drawn indicate 95% CI.